The Effect of Left Ventricular Assist Device Implantation on Serum Albumin, Total Protein and Body Mass: A Short-Term, Longitudinal Follow-Up Study.

[1]  V. Rao,et al.  Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devices. , 2015, The Canadian journal of cardiology.

[2]  T. Imamura,et al.  Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support , 2015, Journal of Artificial Organs.

[3]  H. Kaya,et al.  The prognostic significance of serum albumin in patients with acute decompensated systolic heart failure , 2014, Acta cardiologica.

[4]  W. Hua,et al.  Association of body mass index with cardiac reverse remodeling and long-term outcome in advanced heart failure patients with cardiac resynchronization therapy. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[5]  M. Slaughter,et al.  Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). , 2014, Journal of the American College of Cardiology.

[6]  J. Stulak,et al.  Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device. , 2014, Heart, Lung and Circulation.

[7]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[8]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[9]  Pranav Loyalka,et al.  Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation , 2012, Circulation.

[10]  Pierre Ambrosi,et al.  Human serum albumin in the clinical syndrome of heart failure. , 2011, Journal of cardiac failure.

[11]  A. Hoffmeier,et al.  Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure. , 2010, The Thoracic and cardiovascular surgeon.

[12]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[13]  H. Baba,et al.  Morphological and Molecular Changes of the Myocardium After Left Ventricular Mechanical Support , 2008, Current cardiology reviews.

[14]  G. Fonarow,et al.  Albumin levels predict survival in patients with systolic heart failure. , 2008, American heart journal.

[15]  Mark S. Slaughter,et al.  Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era: Implications for Patient Selection , 2007, Circulation.

[16]  Michael Böhm,et al.  Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology , 2007, European journal of heart failure.

[17]  Abdissa Negassa,et al.  Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study , 2003, The Lancet.

[18]  Heinrich Taegtmeyer,et al.  Obesity and the risk of heart failure. , 2002, The New England journal of medicine.

[19]  M. Slaughter,et al.  Patients with low compared with high body mass index gain more weight after implantation of a continuous-flow left ventricular assist device. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  G. Fonarow,et al.  An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. , 2007, American heart journal.